Infectious Diseases News and Research

RSS

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5355, a clinical trial studying a new cytomegalovirus (CMV) vaccine in adults with both HIV and CMV.

16 Dec 2021

Study details the effectiveness of face masks to reduce the spread of respiratory infections

Findings from a new study published today provide guidance for increasing the effectiveness of face masks to reduce the spread of respiratory infectious pathogens including SARS-CoV-2. T

16 Dec 2021

Researchers spot signs of 'pre-resistance' in bacteria for the first time

Scientists have spotted signs of 'pre-resistance' in bacteria for the first time – signs that particular bacteria are likely to become resistant to antibiotics in the future – in a new study led by UCL and Great Ormond Street Hospital researchers.

15 Dec 2021

Duke Human Vaccine Institute secures federal contract for advancing investigational vaccines

The National Institute of Allergy and Infectious Diseases awarded researchers at the Duke Human Vaccine Institute a contract that enables it to compete for projects advancing investigational vaccines to production for use in early clinical trials.

14 Dec 2021

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

New research from the University of Virginia School of Medicine sheds light on why a fecal transplant can benefit patients with dangerous recurrent C. difficile infections – and suggests a way to improve patient outcomes.

14 Dec 2021

SARS-CoV-2 transmission through indoor aerosols

A recent review published in the International Journal of Indoor Environment and Health presents the science behind the person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an indoor environment.

14 Dec 2021

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

A highly anticipated clinical trial in eight sub-Saharan countries is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV, including those with poorly controlled infections.

13 Dec 2021

CRISPR-Cas enzyme-based diagnostics to detect SARS-CoV-2 infection

A recent review in the journal Life provided a detailed description of CRISPR-Cas-based diagnostic techniques to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but also emphasized the potential use of this technology towards developing effective molecular diagnostic platforms for any future pandemic.

13 Dec 2021

What are the implications of orangutan translocation risks in the COVID-19 era?

Can orangutan translocation pose infectious disease transmission and species conservation threats?

13 Dec 2021

Bioinformatics pipeline can be used to quickly identify SARS-CoV-2 therapeutics

In a new study, researchers developed a bioinformatics pipeline that uses RNA sequencing data to identify altered genes and signaling pathways affected by viral infection.

13 Dec 2021

How LA, calling the shots on school vaccine mandates, can lead the way on covid rules

On March 31, 1977, as a measles epidemic swept through Los Angeles, the county health department issued an ultimatum to the parents of the county's 1.6 million schoolchildren: Get your kids vaccinated within a month or keep them home.

13 Dec 2021

First locally acquired infection of Omicron variant confirmed in San Diego

Officials at the San Diego County Health and Human Services Agency, working in collaboration with scientists at University of California San Diego and Scripps Research, have announced the second confirmed case — and first locally acquired infection — of the Omicron variant of SARS-CoV-2, the virus that causes COVID-19.

12 Dec 2021

LSHTM's new modeling estimates the potential impact of omicron in England

New modeling from the London School of Hygiene & Tropical Medicine suggests the Omicron variant has the potential to cause a wave of transmission in England that could lead to higher levels of cases and hospitalizations than those seen during January 2021, if additional control measures are not taken.

12 Dec 2021

New insights about COVID-19 vaccination rates among people living with HIV

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that insights around COVID-19 vaccination rates among people living with HV have been published in the Journal of Infectious Diseases.

10 Dec 2021

Investigational mRNA-based HIV vaccine shows promise in mice and non-human primates

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

9 Dec 2021

Partnership develops stool sample processing kit to help inform WHO's policy update on childhood TB diagnosis

42 Technology, FIND, the global alliance for diagnostics, and Rutgers University have worked together to develop an innovative stool sample processing kit that has played a central role in informing the World Health Organization’s recent policy update to improve the diagnosis of tuberculosis in children.

9 Dec 2021

New projects aim to identify new solutions to combat antimicrobial-resistant infections

Researchers at Washington University School of Medicine in St. Louis will lead projects aimed at identifying new solutions to help prevent antimicrobial-resistant infections and their spread.

8 Dec 2021

Combination of vaccination and natural infection offers utmost protection against COVID variants

A combination of vaccination and naturally acquired infection appears to boost the production of maximally potent antibodies against the COVID-19 virus, new UCLA research finds.

8 Dec 2021

CDC awards $22 million to fight antimicrobial resistance through the launch of two new networks

The Centers for Disease Control and Prevention (CDC) announced today that it has awarded $22 million to nearly 30 organizations around the world to combat antimicrobial resistance (AR) and other healthcare threats through the establishment of two new networks - the Global Action in Healthcare Network (GAIHN) and the Global AR Laboratory and Response Network (Global AR Lab & Response Network).

7 Dec 2021

People who exercise regularly have lower risk of developing and dying from pneumonia

People who exercise regularly can reduce their risk of developing and dying from pneumonia, new research has found.

7 Dec 2021

Infectious Diseases News and Research

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

Study details the effectiveness of face masks to reduce the spread of respiratory infections

Researchers spot signs of 'pre-resistance' in bacteria for the first time

Duke Human Vaccine Institute secures federal contract for advancing investigational vaccines

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

SARS-CoV-2 transmission through indoor aerosols

Trial in sub-Saharan Africa evaluates the efficacy of COVID-19 vaccine in people living with HIV

CRISPR-Cas enzyme-based diagnostics to detect SARS-CoV-2 infection

What are the implications of orangutan translocation risks in the COVID-19 era?

Bioinformatics pipeline can be used to quickly identify SARS-CoV-2 therapeutics

How LA, calling the shots on school vaccine mandates, can lead the way on covid rules

First locally acquired infection of Omicron variant confirmed in San Diego

LSHTM's new modeling estimates the potential impact of omicron in England

New insights about COVID-19 vaccination rates among people living with HIV

Investigational mRNA-based HIV vaccine shows promise in mice and non-human primates

Partnership develops stool sample processing kit to help inform WHO's policy update on childhood TB diagnosis

New projects aim to identify new solutions to combat antimicrobial-resistant infections

Combination of vaccination and natural infection offers utmost protection against COVID variants

CDC awards $22 million to fight antimicrobial resistance through the launch of two new networks

People who exercise regularly have lower risk of developing and dying from pneumonia

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News